Time: 2024-07-21
Pharmacovigilance is an essential aspect of drug safety monitoring , and with the advancement of technology , the field is witnessing a transformation . Natural language processing ( NLP ) is playing a crucial role in unlocking insights from various sources beyond clinical trials and regulatory filings . Deepanshu Saini , Director of Program Management at IQVIA , categorizes NLP techniques into four broad categories , each contributing to understanding unstructured data in the pharmaceutical world.
One of the fundamental NLP techniques is keyword search , which , although practical and fast , may lack accuracy . Semantic search , on the other hand , can spot synonyms and related terms , providing a more intelligent alternative to keyword - based approaches . This technique explores the meaning and relationships between words , improving the capture of related terms . Early transformer models like BERT have further enhanced NLP capabilities by enabling the model to weigh the importance of all words in a sentence simultaneously , leading to higher accuracy in pharmacovigilance.
Large language models ( LLMs ) have also changed the game in NLP but come with challenges , especially in the context of drug safety monitoring . While LLMs have the potential to process vast amounts of data , their black box nature and the inability to predict outcomes pose validation challenges . Researchers are working on methods to mitigate issues with LLMs , such as Retrieval Augmented Generation ( RAG ) , to ensure grounded outputs in verified information sources.
While NLP tools continue to evolve , they are not used in isolation but as part of a toolbox approach . Pharma companies employ a combination of tools , such as ontologies for semantic search , BERT to reduce false positives , and other techniques to fine - tune results . Human expertise plays a critical role alongside Machine learning algorithms in exploring large datasets of human - categorized information.
Saini emphasizes the importance of not just identifying signals but confirming insights and using them to inform strategies . Pharma companies are advised to design patient support programs and develop educational material based on the signals picked up from social media . Saini highlights the multi - pronged strategy involved in utilizing NLP and ML techniques effectively to make informed decisions and bring about positive changes in drug safety monitoring and patient support programs.